SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 144 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $124,000 | -16.8% | 16,551 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $149,000 | -24.7% | 16,546 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $198,000 | -4.3% | 16,546 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $207,000 | -28.4% | 16,556 | -10.6% | 0.00% | -50.0% |
| Q4 2020 | $289,000 | -19.0% | 18,516 | -50.9% | 0.00% | 0.0% |
| Q3 2020 | $357,000 | -16.6% | 37,749 | -20.9% | 0.00% | -33.3% |
| Q2 2020 | $428,000 | -24.1% | 47,746 | -46.0% | 0.00% | -40.0% |
| Q1 2020 | $564,000 | -23.8% | 88,476 | +0.1% | 0.01% | 0.0% |
| Q4 2019 | $740,000 | +10.6% | 88,376 | +19.5% | 0.01% | 0.0% |
| Q3 2019 | $669,000 | -16.1% | 73,944 | -0.1% | 0.01% | 0.0% |
| Q2 2019 | $797,000 | +150.6% | 74,044 | +122.3% | 0.01% | +150.0% |
| Q1 2019 | $318,000 | -16.8% | 33,314 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $382,000 | -30.3% | 33,314 | +3.1% | 0.00% | -25.0% |
| Q3 2018 | $548,000 | +19.4% | 32,314 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $459,000 | -25.2% | 32,314 | 0.0% | 0.00% | -40.0% |
| Q1 2018 | $614,000 | +15.8% | 32,314 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $530,000 | +9.7% | 32,314 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $483,000 | +70.7% | 32,214 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $283,000 | +68.5% | 32,214 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $168,000 | +71.4% | 32,214 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $98,000 | -34.2% | 32,214 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $149,000 | -22.8% | 32,214 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $193,000 | -1.0% | 32,214 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $195,000 | -33.7% | 32,214 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $294,000 | +61.5% | 32,214 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $182,000 | -49.0% | 32,214 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $357,000 | -10.3% | 32,214 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $398,000 | -34.3% | 32,214 | -19.2% | 0.01% | 0.0% |
| Q4 2014 | $606,000 | +181.9% | 39,888 | +100.0% | 0.01% | +25.0% |
| Q3 2014 | $215,000 | -29.5% | 19,944 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $305,000 | -15.5% | 19,944 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $361,000 | +30.3% | 19,944 | 0.0% | 0.01% | -11.1% |
| Q4 2013 | $277,000 | +32.5% | 19,944 | 0.0% | 0.01% | +28.6% |
| Q3 2013 | $209,000 | +34.0% | 19,944 | 0.0% | 0.01% | +75.0% |
| Q2 2013 | $156,000 | – | 19,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |